Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector Functions
Clicks: 282
ID: 270499
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
282 views
54 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #11 of 34 articles by views in Journal of molecular biology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Antibodies contain a conserved glycosylation site that has emerged as a target for the modulation of antibody effector functions. The crystal structure of a biosynthetic intermediate of human IgG1, bearing immature oligomannose-type glycans and reported to display increased antibody-dependent cellular cytotoxicity, demonstrates that glycan engineering can bias the Fc to an open conformation primed for receptor binding.
| Reference Key |
jones2009journalcarbohydrate
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Max Crispin,Thomas A. Bowden,Charlotte H. Coles,Karl Harlos,A. Radu Aricescu,David J. Harvey,David I. Stuart,E. Yvonne Jones;Max Crispin;Thomas A. Bowden;Charlotte H. Coles;Karl Harlos;A. Radu Aricescu;David J. Harvey;David I. Stuart;E. Yvonne Jones; |
| Journal | Journal of molecular biology |
| Year | 2009 |
| DOI |
10.1016/j.jmb.2009.02.033
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.